Objective: To report the complication rate for a commonly performed procedure (lateral fabellotibial suture [LFS]) used in the treatment of dogs with cranial cruciate ligament (CCL) injury.

Design: Retrospective case series.

Animals: 305 dogs evaluated for 363 incidents of CCL injury from January 1997 through December 2005 and treated with LFS.

Procedures: Medical records were reviewed for information on breed, sex, age, body weight, clinical history, duration of surgery and anesthesia, primary surgeon, percentage of ligament tear, condition of medial meniscus, unilateral versus bilateral disease, implant material, duration of follow-up, and perioperative and postoperative complications.

Results: 363 LFS procedures met the criteria for inclusion in the study. Complications (n=65) were recorded for 63 of the 363 (17.4%) surgical procedures. Multiple complications developed in 2 dogs. In 26 (7.2%) dogs, a second surgery was required to manage the complications. Breed, side on which surgery was performed, implant material, percentage ligament tear, meniscal condition and treatment, bandage use, perioperative antimicrobial use, and experience of surgeon did not influence the complication rate. Factors significantly associated with a higher rate of complications were high body weight and young age of dog at the time of surgery.

Conclusions And Clinical Relevance: LFS is associated with a lower perioperative and postoperative complication rate than has been reported for other surgical procedures to repair CCL injury. Heavier and younger dogs had more complications. Complication rate must be considered when choosing a surgical treatment for dogs with CCL injury.

Download full-text PDF

Source
http://dx.doi.org/10.2460/javma.234.2.229DOI Listing

Publication Analysis

Top Keywords

complication rate
16
ccl injury
12
lateral fabellotibial
8
fabellotibial suture
8
cranial cruciate
8
cruciate ligament
8
treatment dogs
8
body weight
8
percentage ligament
8
ligament tear
8

Similar Publications

Background: Acute pain management is critical in postoperative care, especially in vulnerable patient populations that may be unable to self-report pain levels effectively. Current methods of pain assessment often rely on subjective patient reports or behavioral pain observation tools, which can lead to inconsistencies in pain management. Multimodal pain assessment, integrating physiological and behavioral data, presents an opportunity to create more objective and accurate pain measurement systems.

View Article and Find Full Text PDF

Deep venous thrombosis (DVT) has insidious clinical symptoms, and only a few patients suffer from lower limb swelling, tenderness and dorsal flexion pain. We aimed to explore the ultrasonographic features and risk factors of postoperative lower limb DVT in patients with lower limb fractures. Ninety patients with lower limb fractures admitted from January 1st, 2021 to June 30th, 2023 were selected.

View Article and Find Full Text PDF

Dislocation is the second most common indication for revision total hip arthroplasty (THA). In revision cases the dislocation rate can be as high as 5-30%. The aim of this study was to assess the outcome, specifically the dislocation rate in revision THA where a dual mobility cup was used.

View Article and Find Full Text PDF

Background And Objectives: Although previous trials have established the efficacy and safety of endovascular thrombectomy (EVT) in large ischemic core strokes, most of them excluded patients with extracranial internal carotid artery (e-ICA) occlusion. We aimed to compare outcomes in patients with e-ICA occlusion and large ischemic core infarcts treated with EVT vs medical management (MM).

Methods: This was a secondary analysis of the SELECT2 trial, a randomized controlled trial conducted at 31 international sites.

View Article and Find Full Text PDF

Purpose: Immune checkpoint inhibitors (ICIs) are now first-line therapy for most patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC), and cetuximab is most often used as subsequent therapy. However, data describing cetuximab efficacy in the post-ICI setting are limited.

Methods: We performed a single-institution retrospective analysis of patients with R/M HNSCC treated with cetuximab, either as monotherapy or in combination with chemotherapy, after receiving an ICI.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!